Design, synthesis and preliminary biological evaluation of rivastigmine-INDY hybrids as multitarget ligands against Alzheimer's disease by targeting butyrylcholinesterase and DYRK1A/CLK1 kinases. - Ţînţaş ML; Peauger L; Barré A; Papamicaël C; Besson T; Sopkovà-de Oliveira Santos J; Gembus V; Levacher V (RSC medicinal chemistry, 2024)